MS Group Publications

See the pages of individual authors for papers they have published in fields outside of multiple sclerosis.

2023

Download Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand.

Claflin, S., Campbell, J. A., Norman, R., Mason, D. F., Kalincik, T., Simpson-Yap, S., ... , Taylor, B. V. (2023). Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand. The European Journal of Health Economics, 24, 939–950. 10.1007/s10198-022-01518-x

Download Multiple sclerosis mortality in New Zealand: a nationwide prospective study.

Leadbetter, R., MacAskill, M., Myall, D. J., Taylor, B. V., Joshi, P., Mason, D. F. (2023). Multiple sclerosis mortality in New Zealand: a nationwide prospective study. Journal of Neurology Neurosurgery & Psychiatry, jnnp-2022-33058. 10.1136/jnnp-2022-330582

2018

Download Functional connectivity alterations reveal complex mechanisms based on clinical and radiological status in mild relapsing remitting multiple sclerosis.

Castellazzi, G., Debernard, L., Melzer, T. R., Dalrymple-Alford, J. C., D’Angelo, E., Miller, D. H., Wheeler-Kingshott, C. A., Mason, D. F. (2018). Functional connectivity alterations reveal complex mechanisms based on clinical and radiological status in mild relapsing remitting multiple sclerosis. Frontiers in Neurology, 9, 690. 10.3389/fneur.2018.00690

Open Access Download

2017

Pearson, J. F., Alla, S., Clarke, G., Mason, D. F., Anderson, T., Richardson, A., Miller, D. H., Sabel, C. E., Abernethy, D. A., Willoughby, E. W., Taylor, B. V. (2017). Multiple sclerosis impact on employment and income in New Zealand. Acta Neurologica Scandinavica, 136, 223-232. 10.1111/ane.12714

2016

Alla, S., Pearson, J. F., Taylor, B. V., Miller, D. H., Clarke, G., Richardson, A., Willoughby, E., Abernethy, D. A., Sabel, C. E., Mason, D. F. (2016). Disability profile of multiple sclerosis in New Zealand. Journal of Clinical Neuroscience, 28, 97-101. 10.1016/j.jocn.2015.09.020

Download An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand.

Alla, S., Pearson, J. F., Taylor, B. V., Roxburgh, R., Clarke, G., Miller, D. H., Richardson, A., Abernethy, D. A., Willoughby, E., Sabel, C. E., Mason, D. F. (2016). An investigation of the relationship between latitude and multiple sclerosis severity in New Zealand. Multiple Sclerosis, 22, 705-707. 10.1177/1352458515605909

Mason, D., Pearson, J., Richardson, A., Alla, S. (2016). New Zealand nation-wide population-based multiple sclerosis incidence study shows increasing north-south latitude gradient (Abstract, poster 1, 399). Neurology, 86 (16, Suppl).

2015

Alla, S., Pearson, J. F., Clarke, G., Mason, D. F., Miller, D. H., Richardson, A., Anderson, T., Abernethy, D., Willoughby, E., Sabel, C.E., Taylor, B. V. (2015). Employment among persons with multiple sclerosis in New Zealand (Abstract). Multiple Sclerosis Journal, 23(11, Suppl.), 419. 10.1177/1352458515602642

Alla, S., Pearson, J. F., Taylor, B. V., Miller, D. H., Richardson, A., Clarke, G., Abernethy, D., Willoughby, E., Sabel, C.E., Mason, D. F. (2015). Age has an effect on disability independent of age at onset of symptoms and disease duration (Abstract). Multiple Sclerosis Journal, 23(11, Suppl.), 397-398. 10.1177/1352458515602642

Alla, S., Taylor, B. V., Pearson, J. F., Richardson, A., Miller, D. H., Clarke, G., Abernethy, D., Willoughby, E., Sabel, C.E., Mason, D. F. (2015). Characteristics of familial multiple sclerosis in New Zealand: A country-wide population based study (Abstract). Multiple Sclerosis Journal, 23 (11, Suppl.), 722. 10.1177/1352458515602639

Download A new era in the treatment of multiple sclerosis.

Broadley, S. A., Barnett, M. H., Boggild, M., Brew, B. J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A. G., Lechner-Scott, J., Macdonell, R. A., Marriott, M., Mason, D. F., Parratt, J., Reddel, S. W., Shaw, C. P., Slee, M., Spies, J. M., Taylor, B. V., Carroll, W. M., Kilpatrick, T. J., . . . Willoughby, E. (2015). A new era in the treatment of multiple sclerosis. Medical Journal of Australia, 203(3), 139-141. 10.5694/mja14.01218

Download Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.

Debernard, L., Melzer, T. R., Alla, S., Eagle, J., Van Stockum, S., Graham, C., Osborne, J. R., Dalrymple-Alford, J. C., Miller, D. H., Mason, D. F. (2015). Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis. Psychiatry Research: Neuroimaging. 10.1016/j.pscychresns.2015.10.00

Download A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.

Gu, B. J., Field, J., Dutertre, S., Ou, A., Kilpatrick, T. J., Lechner-Scott, J., Scott, R., Lea, R., Taylor, B. V., Stankovich, J., Butzkueven, H., Gresle, M., Laws, S. M., Petrou, S., Hoffjan, S., Akkad, D. A., Graham, C. A., Hawkins, S., Glaser, A., Bedri, S. K., . . . Wiley, J. S. (2015). A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis. Human Molecular Genetics, 24(19), 5644-54. 10.1093/hmg/ddv278

Download Safety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosis.

Luckey, A. M., Anderson, T., Silverman, M. H., Webster, G. (2015). Safety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosis. Multiple Sclerosis - Journal Experimental, Translational and Clinical, 1, 205521731558338. 10.1177/ 2055217315583385

2014

Alla, S, Pearson, J, Richardson, A, Mason, D. (2014). The incidence of multiple sclerosis in New Zealand: a prospective, nationwide population-based study (Abstract). Multiple Sclerosis Journal, 20:(S1), 220. 10.1177/1352458514546077

Download Multiple sclerosis in New Zealand.

Alla, S. , Mason, D.F. (2014). Multiple sclerosis in New Zealand. Journal of Clinical Neuroscience, 21, 1288-1291. 10.1016/j.jocn.2013.09.009

Download The increasing prevalence of multiple sclerosis in New Zealand.

Alla, S., Pearson, J., Debernard, L., Miller, D. , Mason, D. (2014). The increasing prevalence of multiple sclerosis in New Zealand. Neuroepidemiology, 42, 154-16. 10.1007/s00702-013-1123-9

Download Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.

Debernard, L., Melzer, T. R., Van Stockum, S., Graham, C., Wheeler-Kingshott, C. A., Dalrymple-Alford, J. C., Miller, D. H. , Mason, D.F. (2014). Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry, 85. 10.1136/jnnp-2013-305612

Download Multiple sclerosis in New Zealand Maori.

Pearson, J. F., Alla, S., Clarke, G., Taylor, B. V., Miller, D. H., Richardson, A., Mason, D.F. (2014). Multiple sclerosis in New Zealand Maori. Multiple Sclerosis, 20(14), 1892-1895. 10.1177/1352458514535130

Download Optic neuritis.

Toosy, A. T., Mason, D. F., Miller, D.H. (2014). Optic neuritis. Lancet Neurology, 13, 83-99. 10.1016/S1474-4422(13)70259-X

2013

Debernard, L., Alla, S., Melzer, T., Van Stockum, S., Graham, C., Dalrymple-Alford, J., Miller, DH, Mason, D (2013). Cortical perfusion is associated with cognitive function in relapsing remitting multiple sclerosis patients (Abstract). Multiple Sclerosis, 19(S11), 171. 10.1177/1352458513502429

Download (2013), Analysis of Immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

The International Multiple Sclerois Genetics Consortium (2013). (2013), Analysis of Immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45, 1353-1360.

2012

Download A review of interferon use in patients with relapsing remitting multiple sclerosis in the Canterbury region, New Zealand 2000-2006.

Byrne, S., Mason, D. (2012). A review of interferon use in patients with relapsing remitting multiple sclerosis in the Canterbury region, New Zealand 2000-2006. New Zealand Medical Journal, 125 (1350, 37-44.

Richardson, A. K., Clarke, G., Sabel, C. E., Pearson, J. F., Mason, D. F., Taylor, B.V. (2012). Method for identifying eligible individuals for a prevalence survey in the absence of a disease register or population register. International Medical Journal, 42, 1207-1212.

Download Geographical variations in sex ratio trends over time in multiple sclerosis.

Trojano, M., Lucchese, G., Graziano, G., Taylor, B. V., Simpson, S. J., Lepore, V., Grand'maison, F., Duquette, P., Izquierdo, G., Grammond, P., Amato, M. P., Bergamaschi, R., Giuliani, G., Boz, C., Hupperts, R. et al. , on behalf of the MSBase Study Group and the New Zealand MS Prevalence Study Group (2012). Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS One, 7, e48078.. 10.1371/journal.pone.0048078

Open Access Download

2011

Download and the Wellcome Trust Case Control Consortium 2 (WTCCC2) (2011), Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

The International Multiple Sclerosis Genetics Consortium (2011). and the Wellcome Trust Case Control Consortium 2 (WTCCC2) (2011), Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature, 476, 214-219. 10.1038/nature10251

2010

Download MS prevalence in New Zealand, an ethnically and latitudinally diverse country.

Taylor, B. V., Pearson, J. F., Clarke, G., Mason, D. F., Abernethy, D. A., Willoughby, E., Sabel, C. (2010). MS prevalence in New Zealand, an ethnically and latitudinally diverse country. Multiple Sclerosis, 16, 1422-1431. 10.1177/1352458510379614

2009

Download Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.

Australia and New Zealand Multiple Sclerosis Genetics Consortium (2009). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nature Genetics, 41, 824-828. 10.1038/ng.396

2004

Canadian MS Working Group (2004). Treatment optimization in multiple sclerosis. Canadian Journal of Neurological Science, 31, 157-168.

1990

Anderson, T., Donaldson, I. M., Sheat, J. , George, P. (1990). Methylprednisolone in multiple sclerosis exacerbation: changes in CSF parameters. Australian and New Zealand Journal of Medicine, 20, 794.